Search Results

There are 32347 results for: content related to: Construction and humanization of a functional bispecific EGFR × CD16 diabody using a refolding system

  1. You have free access to this content
    Multiple Domains in PEX16 Mediate Its Trafficking and Recruitment of Peroxisomal Proteins to the ER

    Traffic

    Volume 16, Issue 8, August 2015, Pages: 832–852, Rong Hua, Satinder K. Gidda, Alexander Aranovich, Robert T. Mullen and Peter K. Kim

    Version of Record online : 12 MAY 2015, DOI: 10.1111/tra.12292

  2. You have free access to this content
    Application of the Fc fusion format to generate tag-free bi-specific diabodies

    The FEBS Journal

    Volume 277, Issue 2, January 2010, Pages: 477–487, Ryutaro Asano, Keiko Ikoma, Hiroko Kawaguchi, Yuna Ishiyama, Takeshi Nakanishi, Mitsuo Umetsu, Hiroki Hayashi, Yu Katayose, Michiaki Unno, Toshio Kudo and Izumi Kumagai

    Version of Record online : 15 DEC 2009, DOI: 10.1111/j.1742-4658.2009.07499.x

  3. Clinical pharmacology of bispecific antibody constructs

    The Journal of Clinical Pharmacology

    Volume 55, Issue S3, March 2015, Pages: S21–S28, Chetan Rathi and Bernd Meibohm

    Version of Record online : 23 FEB 2015, DOI: 10.1002/jcph.445

  4. You have free access to this content
    The novel bispecific diabody αCD40/αCD28 strengthens leukaemic dendritic cell-induced T-cell reactivity

    British Journal of Haematology

    Volume 142, Issue 2, July 2008, Pages: 273–283, Ilse Houtenbos, Saskia Santegoets, Theresia M. Westers, Quinten Waisfisz, Sergey Kipriyanov, Fedor Denkers, Rik J. Scheper, Tanja D. De Gruijl, Gert J. Ossenkoppele and Arjan A. Van De Loosdrecht

    Version of Record online : 28 JUN 2008, DOI: 10.1111/j.1365-2141.2008.06990.x

  5. You have free access to this content
    Requirement for Microtubules and Dynein Motors in the Earliest Stages of Peroxisome Biogenesis

    Traffic

    Volume 6, Issue 5, May 2005, Pages: 386–395, Cécile B. Brocard, Krissy K. Boucher, Christopher Jedeszko, Peter K. Kim and Paul A. Walton

    Version of Record online : 22 MAR 2005, DOI: 10.1111/j.1600-0854.2005.00283.x

  6. You have free access to this content
    The Role of Conserved PEX3 Regions in PEX19-Binding and Peroxisome Biogenesis

    Traffic

    Volume 13, Issue 9, September 2012, Pages: 1244–1260, Friederike Schmidt, Denise Dietrich, Roy Eylenstein, Yvonne Groemping, Thilo Stehle and Gabriele Dodt

    Version of Record online : 19 JUN 2012, DOI: 10.1111/j.1600-0854.2012.01380.x

  7. You have free access to this content
    CD3× anti-nitrophenyl bispecific diabodies: Universal immunotherapeutic tools for retargeting T cells to tumors

    International Journal of Cancer

    Volume 82, Issue 5, 27 August 1999, Pages: 700–708, Oliver Manzke, Kevin J. Fitzgerald, Philipp Holliger, Jochen Klock, Mary Span, Bernd Fleischmann, Juergen Hescheler, Liu Qinghua, Kevin S. Johnson, Volker Diehl, Hennie R. Hoogenboom and Heribert Bohlen

    Version of Record online : 10 NOV 1999, DOI: 10.1002/(SICI)1097-0215(19990827)82:5<700::AID-IJC13>3.0.CO;2-2

  8. Effective targeting of prostate cancer by lymphocytes redirected by a PSMA × CD3 bispecific single-chain diabody

    The Prostate

    Volume 71, Issue 6, May 2011, Pages: 588–596, Kerstin Fortmüller, Karen Alt, Dorothee Gierschner, Philipp Wolf, Volker Baum, Nikolaus Freudenberg, Ulrich Wetterauer, Ursula Elsässer-Beile and Patrick Bühler

    Version of Record online : 13 OCT 2010, DOI: 10.1002/pros.21274

  9. Bispecific Antibodies

    Handbook of Therapeutic Antibodies

    Dafne Müller, Roland E. Kontermann, Pages: 345–378, 2008

    Published Online : 1 FEB 2008, DOI: 10.1002/9783527619740.ch15

  10. Bispecific Antibodies and Immune Therapy Targeting

    Drug Delivery in Oncology: From Basic Research to Cancer Therapy

    Felix Kratz, Peter Senter, Henning Steinhagen, Pages: 441–482, 2011

    Published Online : 16 DEC 2011, DOI: 10.1002/9783527634057.ch16

  11. You have free access to this content
    Therapeutic antibodies: successes, limitations and hopes for the future

    British Journal of Pharmacology

    Volume 157, Issue 2, May 2009, Pages: 220–233, Patrick Chames, Marc Van Regenmortel, Etienne Weiss and Daniel Baty

    Version of Record online : 28 APR 2009, DOI: 10.1111/j.1476-5381.2009.00190.x

  12. You have free access to this content
    Novel tetravalent and bispecific IgG-like antibody molecules combining single-chain diabodies with the immunoglobulin γ1 Fc or CH3 region

    FEBS Letters

    Volume 454, Issue 1-2, July 02, 1999, Pages: 90–94, Margitta Alt, Rolf Müller and Roland E Kontermann

    Version of Record online : 6 JUL 1999, DOI: 10.1016/S0014-5793(99)00782-6

  13. Recombinant bispecific antibodies for cancer therapy

    Acta Pharmacologica Sinica

    Volume 26, Issue 1, January 2005, Pages: 1–9, Roland E KONTERMANN

    Version of Record online : 13 JAN 2005, DOI: 10.1111/j.1745-7254.2005.00008.x

  14. You have free access to this content
    Bispecific CD3 × CD19 diabody for T cell-mediated lysis of malignant human B cells

    International Journal of Cancer

    Volume 77, Issue 5, 31 August 1998, Pages: 763–772, Sergey M. Kipriyanov, Gerhard Moldenhauer, Gudrun Strauss and Melvyn Little

    Version of Record online : 6 DEC 1998, DOI: 10.1002/(SICI)1097-0215(19980831)77:5<763::AID-IJC16>3.0.CO;2-2

  15. Inducible nitric oxide synthase promoter polymorphism: a molecular susceptibility marker for vitiligo in Egyptians

    International Journal of Dermatology

    Volume 54, Issue 6, June 2015, Pages: 675–679, Amira A. Zayed, Mervat M. Khorshied and Marwa F. Hussein

    Version of Record online : 29 DEC 2014, DOI: 10.1111/ijd.12716

  16. Influence of the additive type and modification on the properties of blends of polyamide-6 with poly(styrene-co-maleic anhydride)

    Polymer Engineering & Science

    Volume 39, Issue 6, June 1999, Pages: 985–995, I. Kelnar, I. Fortelný, M. Stephan and L. Jakisch

    Version of Record online : 8 APR 2004, DOI: 10.1002/pen.11488

  17. Recombinant approaches to IgG-like bispecific antibodies

    Acta Pharmacologica Sinica

    Volume 26, Issue 6, June 2005, Pages: 649–658, Jonathan S MARVIN and Zhenping ZHU

    Version of Record online : 23 MAY 2005, DOI: 10.1111/j.1745-7254.2005.00119.x

  18. You have free access to this content
    Bispecific targeting of thrombin activatable fibrinolysis inhibitor and plasminogen activator inhibitor-1 by a heterodimer diabody

    Journal of Thrombosis and Haemostasis

    Volume 6, Issue 11, November 2008, Pages: 1884–1891, J. DEVELTER, N. A. BOOTH, P. J. DECLERCK and A. GILS

    Version of Record online : 22 AUG 2008, DOI: 10.1111/j.1538-7836.2008.03137.x

  19. You have free access to this content
    Effect of tetravalent bispecific CD19×CD3 recombinant antibody construct and CD28 costimulation on lysis of malignant B cells from patients with chronic lymphocytic leukemia by autologous T cells

    International Journal of Cancer

    Volume 112, Issue 3, 10 November 2004, Pages: 509–518, Uwe Reusch, Fabrice Le Gall, Manfred Hensel, Gerhard Moldenhauer, Anthony D. Ho, Melvyn Little and Sergey M. Kipriyanov

    Version of Record online : 16 JUN 2004, DOI: 10.1002/ijc.20417

  20. KIAA1549-BRAF Fusions and IDH Mutations Can Coexist in Diffuse Gliomas of Adults

    Brain Pathology

    Volume 22, Issue 6, November 2012, Pages: 841–847, Manuela Badiali, Vincent Gleize, Sophie Paris, Loredana Moi, Selma Elhouadani, Antonietta Arcella, Roberta Morace, Manila Antonelli, Francesca Romana Buttarelli, Dominique Figarella- Branger, Young-Ho Kim, Hiroko Ohgaki, Karima Mokhtari, Marc Sanson and Felice Giangaspero

    Version of Record online : 18 JUN 2012, DOI: 10.1111/j.1750-3639.2012.00603.x